PT-141 (Bremelanotide)
Boosts libido and sexual desire. A melanocortin agonist, FDA-approved as Vyleesi for female sexual dysfunction and used off-label for libido in both sexes.
PT-141 (Bremelanotide): Boosts libido and sexual desire. A melanocortin agonist, FDA-approved as Vyleesi for female sexual dysfunction and used off-label for libido in both sexes. PT-141 (FDA-approved as Vyleesi) is the libido peptide.
PT-141 (FDA-approved as Vyleesi) is the libido peptide. Different mechanism than Viagra, it works on desire, not just blood flow. Used as-needed, not daily. Nausea is the main side effect, especially the first few times.
FDA-approved drug. Most federations would not consider it disqualifying for libido use, but each federation has its own rules.
Approved as Vyleesi (Bremelanotide), 2019, for hypoactive sexual desire disorder in premenopausal women.
Yes, Vyleesi prescribed by gynecology, primary care, sexual-medicine providers.
Who it's for
- →Users with situational or low-baseline libido
- →Couples wanting a non-PDE5-inhibitor option
- →People for whom Viagra/Cialis don't address the desire side
What to expect
- Week 1
Effect within hours of first dose. Nausea common at first.
- Week 4
Tolerance to nausea builds. Effect remains.
- Week 8
Used episodically rather than continuously.
Looking at PT-141 (Bremelanotide)? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for PT-141 (Bremelanotide).
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Melanocortin-receptor agonist (MC3R + MC4R) that acts centrally on arousal pathways in the brain rather than peripherally on blood flow (which is what PDE5 inhibitors like Viagra do). Different lever, desire vs vasodilation.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Uncontrolled hypertension
- ⚠Cardiovascular disease
- ⚠Personal history of melanoma
Bloodwork to monitor
- • Blood pressure baseline if using regularly
Common mistakes
- • Dosing too high on first use (nausea will dominate the experience)
- • Using daily instead of as-needed
- • Pairing with alcohol, amplifies nausea
Drug & supplement interactions
- ⚠Antihypertensives: PT-141 transiently elevates BP
- ⚠MAO inhibitors: theoretical melanocortin amplification
- ⚠Oral naltrexone: avoid, PT-141 slows gastric emptying and cuts naltrexone absorption ~40-60% (FDA label)
- ⚠Alcohol: compounds nausea, most users avoid alcohol within 4 hours of dose
- ⚠Maximum 1 dose per 24h; max 8 doses per month per FDA label
The Pepdex take
The bedroom peptide. It works, but the nausea on first use is no joke. Start at 0.75-1mg sub-q, NOT the labeled 1.75mg starter dose that vendors copy from the FDA-approved Vyleesi label. Anyone telling you to start at 1.75 hasn't actually run it. Time it 4-6 hours before you want the effect, not 1 hour. As-needed only, daily use blunts the response and amplifies the BP impact.
Community patterns
New to PT-141 (Bremelanotide)? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if PT-141 (Bremelanotide) changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about PT-141 (Bremelanotide) or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →